DATASHEET
Host:
Rabbit
Target Protein:
TLR9
Immunogen Range:
401-500/1032
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
Q9NR96
Swiss Prot:
54106
Source:
KLH conjugated synthetic peptide derived from human TLR9
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Store at -20°C for 12 months.
Background:
The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is preferentially expressed in immune cell rich tissues, such as spleen, lymph node, bone marrow and peripheral blood leukocytes. Studies in mice and human indicate that this receptor mediates cellular response to unmethylated CpG dinucleotides in bacterial DNA to mount an innate immune response. [provided by RefSeq, Jul 2008]
PRODUCT SPECIFIC PUBLICATIONS
- Yang Jun-Pu. et al. Glycyrrhizin ameliorates impaired glucose metabolism and ovarian dysfunction in a polycystic ovary syndrome mouse model. BIOL REPROD. 2023 ApRead more>>
- Xiao Chen. et al. Controlling Alveolar Bone Loss by Hydrogel-Based Mitigation of Oral Dysbiosis and Bacteria-Triggered Proinflammatory Immune Response. ADV FUNCT MATER. 2024 Aug;:2409121Read more>>
VALIDATION IMAGES
Sample:
Testis (Mouse) Lysate at 40 ug
Primary: Anti- TLR9 (bs-23640R) at 1/1000 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 113 kD
Observed band size: 120 kD
Lane 1: Human SH-SY5Y cell lysates; Lane 2: Human HeLa cell lysates probed with TLR9 Polyclonal Antibody, Unconjugated (bs-23640R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.